https://www.selleckchem.com/pr....oducts/phorbol-12-my
ALK rearranged renal cell carcinoma (ALK-RCC) has recently been included in 2016 WHO classification as a provisional entity. In this study, we describe 12 ALK-RCCs from 8 institutions, with detailed clinical, pathological, immunohistochemical (IHC), fluorescence in situ hybridization (FISH), and next generation sequencing (NGS) analyses. Patients' age ranged from 25 to 68 years (mean, 46.3 years). Seven patients were females and five were males (MF = 11.4). Tumor size ranged from 17 to 70 mm (mean 31.5, median 25
Like
Comment
Share
